Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
193.52
205.45
209.36
188.00
177.76
181.95
159.30
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
193.52
205.45
209.36
188.00
177.76
181.95
159.30
Raw Material Cost
76.27
77.07
80.19
79.62
80.43
83.66
62.51
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
15.86
19.29
21.77
20.46
20.79
22.65
18.39
Selling and Distribution Expenses
85.28
67.24
65.55
72.70
73.74
58.65
42.07
Other Expenses
-1.59
-1.93
-2.18
-2.05
-2.08
-2.27
-1.84
Total Expenditure (Excl Depreciation)
161.56
144.31
145.74
152.32
154.17
142.31
104.58
Operating Profit (PBDIT) excl Other Income
32
61.1
63.6
35.699999999999996
23.599999999999998
39.6
54.699999999999996
Other Income
3.71
3.56
3.12
2.38
2.23
1.81
3.28
Operating Profit (PBDIT)
91.61
121.10
123.24
94.67
82.38
97.96
99.75
Interest
15.86
19.29
21.77
20.46
20.79
22.65
18.39
Exceptional Items
-1.07
-16.37
-1.53
-0.58
-1.90
-1.53
-24.03
Gross Profit (PBDT)
117.25
128.38
129.17
108.38
97.32
98.29
96.79
Depreciation
55.94
56.40
56.51
56.61
56.56
56.51
41.75
Profit Before Tax
18.74
29.04
43.44
17.02
3.12
17.27
15.58
Tax
4.24
12.07
11.93
5.04
0.70
4.73
6.25
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
14.50
16.96
31.51
11.98
2.42
12.54
9.34
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
14.50
16.96
31.51
11.98
2.42
12.54
9.34
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
14.50
16.96
31.51
11.98
2.42
12.54
9.34
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
312.42
301.68
274.81
232.21
234.43
228.84
234.28
Earnings per share (EPS)
0.4
0.46
0.84
0.34
0.07
0.35
0.27
Diluted Earnings per share
0.4
0.46
0.84
0.34
0.07
0.35
0.27
Operating Profit Margin (Excl OI)
16.52%
29.76%
30.39%
18.98%
13.27%
21.79%
34.35%
Gross Profit Margin
38.59%
41.58%
47.74%
39.17%
33.58%
40.55%
35.99%
PAT Margin
7.49%
8.26%
15.05%
6.37%
1.36%
6.89%
5.86%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is -5.79% vs -1.91% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -14.71% vs -46.03% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is -25.19% vs -2.16% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is -17.62% vs -11.47% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
Compare Quarterly Results Of Collegium Pharmaceutical, Inc. With
Figures in Million
Consolidate Quarterly Results
Change(USD)
Change(%)
Net Sales
193.52
101.45
92.07
90.75%
Other Operating Income
0.00
0.00
0.00
Total Operating income
193.52
101.45
92.07
90.75%
Raw Material Cost
76.27
25.62
50.65
197.70%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
15.86
5.44
10.42
191.54%
Selling and Distribution Expenses
85.28
32.44
52.84
162.89%
Other Expenses
-1.59
-0.02
-1.57
-7,850.00%
Total Expenditure (Excl Depreciation)
161.56
63.30
98.26
155.23%
Operating Profit (PBDIT) excl Other Income
31.97
38.15
-6.18
-16.20%
Other Income
3.71
10.62
-6.91
-65.07%
Operating Profit (PBDIT)
91.61
58.82
32.79
55.75%
Interest
15.86
5.44
10.42
191.54%
Exceptional Items
-1.07
191.22
-192.29
-100.56%
Gross Profit (PBDT)
117.25
75.83
41.42
54.62%
Depreciation
55.94
10.04
45.90
457.17%
Profit Before Tax
18.74
234.56
-215.82
-92.01%
Tax
4.24
47.97
-43.73
-91.16%
Provisions and contingencies
0
0
0.00
Profit After Tax
14.50
186.59
-172.09
-92.23%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
14.50
186.59
-172.09
-92.23%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
14.50
186.59
-172.09
-92.23%
Equity Capital
0
0
0.00
Face Value
0.00
0.01
0.00
Reserves
312.42
1,341.65
-1,029.23
-76.71%
Earnings per share (EPS)
0.40
2.22
-1.82
-81.98%
Diluted Earnings per share
0.40
2.22
-1.82
-81.98%
Operating Profit Margin (Excl OI)
16.52%
37.61%
0.00
-21.09%
Gross Profit Margin
38.59%
241.11%
0.00
-202.52%
PAT Margin
7.49%
183.93%
0.00
-176.44%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 19.35 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is -5.79% vs -1.91% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 8.83% vs 22.71% in Mar 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 1.45 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is -14.71% vs -46.03% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 504.17% vs -91.34% in Mar 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 8.79 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is -25.19% vs -2.16% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 9.60% vs -5.54% in Mar 2025
Quarterly - Interest
Interest 1.59 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is -17.62% vs -11.47% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -23.56% vs 20.23% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.52%
in Mar 2026Figures in %
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
